Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-04 4:41 pm Sale | 2023-07-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 3,653,120 14.600% | -1,582,836 (-30.23%) | Filing History |
| 2023-02-14 11:36 am Purchase | 2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 5,235,956 17.000% | 4,468 (+0.09%) | Filing History |
| 2023-02-13 5:16 pm Purchase | 2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Peyer James | 5,235,956 17.000% | 5,235,956 (New Position) | Filing History |
| 2022-06-10 2:18 pm Purchase | 2021-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Cambrian BioPharma Inc | 5,231,488 17.100% | 5,231,488 (New Position) | Filing History |